Asia Pac Allergy.  2014 Jan;4(1):32-36. 10.5415/apallergy.2014.4.1.32.

The pH of antiseptic cleansers

• Kulthanan
• Maneeprasopchoke P
• Varothai S
• Nuchkull P

• KMID: 2397123
• DOI: http://doi.org/10.5415/apallergy.2014.4.1.32

Abstract

BACKGROUND
Daily bathing with antiseptic cleansers are proposed by some physicians as an adjunctive management of atopic dermatitis (AD). As atopic skin is sensitive, selection of cleansing products becomes a topic of concern.
OBJECTIVE
Our purpose is to evaluate the pH of various antiseptic body cleansers to give an overview for recommendation to patients with AD.
METHODS
Commonly bar and liquid cleansers consisted of antiseptic agents were measured for pH using pH meter and pH-indicator strips. For comparison, mild cleansers and general body cleansers were also measured.
RESULTS
All cleansing bars had pH 9.8-11.3 except syndet bar that had neutral pH. For liquid cleansers, three cleansing agents had pH close to pH of normal skin, one of antiseptic cleansers, one of mild cleansers and another one of general cleansers. The rest of antiseptic cleansers had pH 8.9-9.6 while mild cleansers had pH 6.9-7.5. Syndet liquid had pH 7 and general liquid cleansers had pH 9.6.
CONCLUSION
The pH of cleanser depends on composition of that cleanser. Adding antiseptic agents are not the only factor determining variation of pH. Moreover, benefit of antiseptic properties should be considered especially in cases of infected skin lesions in the selection of proper cleansers for patients with AD.

Keyword

pH; Cleanser; Antiseptic; Atopic; Dermatitis

MeSH Terms

Baths
Dermatitis
Dermatitis, Atopic
Detergents
Humans
Hydrogen-Ion Concentration*
Skin
Detergents

Reference

1. Ong PY, Leung DY. The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010; 30:309–321.

2. Leung AD, Schiltz AM, Hall CF, Liu AH. Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus. Clin Exp Allergy. 2008; 38:789–793.

3. Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006; 155:680–687.

4. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol. 2006; 144:1–9.

5. Breneman DL, Hanifin JM, Berge CA, Keswick BH, Neumann PB. The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis. 2000; 66:296–300.

6. Braun-Falco O, Korting HC. Normal pH value of human skin. Hautarzt. 1986; 37:126–129.

7. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol. 2004; 5:217–223.

8. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006; 28:359–370.

9. Parra JL, Paye M. EEMCO Group. EEMCO guidance for the in vivo assessment of skin surface pH. Skin Pharmacol Appl Skin Physiol. 2003; 16:188–202.

10. Korting HC, Braun-Falco O. The effect of detergents on skin pH and its consequences. Clin Dermatol. 1996; 14:23–27.

11. Gfatter R, Hackl P, Braun F. Effects of soap and detergents on skin surface pH, stratum corneum hydration and fat content in infants. Dermatology. 1997; 195:258–262.

12. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004; 17:Suppl 1. 16–25.

13. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125:4–13.

14. Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J Allergy Clin Immunol. 2006; 118:40–43.

15. Craig FE, Smith EV, Williams HC. Bleach baths to reduce severity of atopic dermatitis colonized by Staphylococcus. Arch Dermatol. 2010; 146:541–543.

16. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009; 123:e808–e814.

17. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 1998; 139:Suppl 53. 13–16.

18. Schnopp C, Ring J, Mempel M. The role of antibacterial therapy in atopic eczema. Expert Opin Pharmacother. 2010; 11:929–936.

19. Harper J. Double-blind comparison of an antiseptic oil-based bath additive (Oilatum Plus) with regular Oilatum (Oilatum emollient) for the treatment of atopic eczema. In : Lever R, Levy J, editors. The Bacteriology of eczema. London: The Royal Society of Medicine Press Limited;1995. p. 42–47.

20. Tan WP, Suresh S, Tey HL, Chiam LY, Goon AT. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis. Clin Exp Dermatol. 2010; 35:e109–e112.

21. Gelmetti C. Skin cleansing in children. J Eur Acad Dermatol Venereol. 2001; 15:Suppl 1. 12–15.

22. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009; 9:437–446.

23. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol. 2010; 163:12–26.

24. World Health Organization. WHO guidelines on hand hygiene in health care: first global patient safety challenge clean care is safer care. Geneva: World Health Organization;2009.

25. Atiyeh BS, Dibo SA, Hayek SN. Wound cleansing, topical antiseptics and wound healing. Int Wound J. 2009; 6:420–430.

26. Corazza M, Lauriola MM, Zappaterra M, Bianchi A, Virgili A. Surfactants, skin cleansing protagonists. J Eur Acad Dermatol Venereol. 2010; 24:1–6.

27. Hannuksela A, Hannuksela M. Soaps and detergents in skin diseases. Clin Dermatol. 1996; 14:77–80.

28. Bikowski J. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis. 2001; 68:12–19.

29. Kuehl BL, Fyfe KS, Shear NH. Cutaneous cleansers. Skin Therapy Lett. 2003; 8:1–4.

30. Abbas S, Goldberg JW, Massaro M. Personal cleanser technology and clinical performance. Dermatol Ther. 2004; 17:Suppl 1. 35–42.

31. Nix DH. Factors to consider when selecting skin cleansing products. J Wound Ostomy Continence Nurs. 2000; 27:260–268.

32. Baranda L, González-Amaro R, Torres-Alvarez B, Alvarez C, Ramírez V. Correlation between pH and irritant effect of cleansers marketed for dry skin. Int J Dermatol. 2002; 41:494–499.